Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
this guy said they were going in the clinic and they completed a preIND w FDA. that's significant step fwd if anything materializes. that was a milestone for past 3years on their presentations if they actually moved past this step with the cash they claim to have on hand this this thing could move to phase 2 fairly quickly...could it be???
Skye recently updated its clinical development strategy and timeline for its Phase I study, focused on safety and tolerability in 48 healthy volunteers, which is being initiated in Q2-22 in Australia.
I'll believe it when I see it. I've seen this data when they were NMUS, then when they were EMBI, now SKYE has managed to regurgitate the same useless press release. This isn't some new company this is same bag of crap it was 3 names ago. Another Dhillon dumpster fire...outstanding
they just created another 80M shares w warrants that need to be sold
Punit way to driver shareholder value. This will be the story of an incompetent idiot who churns and burns this shell to zero. Way to go asshole
Citron once shorted all of Emerald companies w/o much care as to which or why and that really depressed this thing when it had quite a nice run prior. Now that it's on its own this company has value little to no debt or overhang so sky is limit. When is this phase 1 data and Australia development happening. All other stocks in industry are taking part in rally we're still on sidelines.
Out of the pot and onto the frying pan. Punit has zero pedigree has a liberal arts degree from some unknown school and looks like he’s a real winner from what I can find on google about him. What a waste of time and money.
https://ir.emeraldbio.life/news-events/press-releases/detail/90/emerald-bioscience-announces-notice-of-allowance-from
When there’s good news nobody notices
Punit is a piece of crap I blame his involvement in this sell off
EHS is in spiral down with rest of Canada. EMBI is one piece of their portfolio that can disassociate itself easily, I can see this getting relief from somebody
Reducing debt and warrant liability is good (minus the 30 million shares of added dilution). The $15 million they seem to be set on raising with everything else happening could be the push to put stock on major exchange like NASDAQ. They probably could care less if they have 300 million share float since they would probably reverse split 15-1 to get it done. The 1st Q of 2020 will be make or break time. Hope I’m right about what seems like is starting to unfold
Looks like they elected the $.10 warrants and paid down 2/3 of the debt. There looks to be a ray of hope for a big announcement here. Maybe these Dhilons aren’t as completely useless as I thought for the past 3 months. Another 40 million shares added but 10 million reduced from convertible debt.
Emerald Health (parent group) is on brink of collapse. The Canadian companies are all getting brought back to reality and they are a somewhat smaller insignificant player so rocky road ahead for sure
that's an error on the blog i believe i searched everywhere to see what type of notice they could have possibly gotten. Since the Dillon idiots are so smart they named the company and cloned the ticker symbol emerging markets bond index which did have something yesterday. road to nowhere continues though
No preIND no progress just more dilution. Emerald may be the most incompetent group of idiots in Canada.
Avatr's well is running dry this is not focal point of his little emerald empire. Someone will put the $ money in and they will get their data it's just at what level of dilution.
Press release sounds like I’ve heard it before. Where’s the preIND? Timeline pushed back again. Stop the fluff
Days to cover is growing this could be the ramp we would like to see happening
SHORT INTEREST
DATE SHORT INTEREST % CHANGE AVG. DAILY SHARE VOL DAYS TO COVER SPLIT NEW ISSUE
08/30/2019 408,540 0.02 121,176 3.37 No No
08/15/2019 427,396 4.63 182,842 2.34 No No
07/31/2019 408,491 9.71 157,310 2.6 No No
07/15/2019 372,327 77.66 370,339 1.01 No No
The way this thing held ground against the slaughter in MMJ market yesterday, I’m actually looking forward to announcement that may be driving this. Maybe they actually have preIND which is next logical step into actually conducting human studies
Dead cat bounce
Murphy speaks again today. Seems like there’s more buyers since he started the conference tours last week. Maybe Dr. Murphy has tipped his hand to some impending good news. Although his presentation looked like it still had the same ground breaking nothing data about lowering IOP it’s had for past 3 years, who knows maybe this time will be different ???????
Cant wait to hear the same presentation pushing same projected dates back another 6 months
New CMO came over from another emerald company. Any thoughts??
i remember during tech bubble days watching day traders just get wiped out by sudden euphoria...this has the same eerie feeling
who sells 50,000+ shares of this stock @.28??? Theres only about 50 million unrestricted shares...it's a matter of time before sellers get burned.. I'm not the smartest guy on earth but there's a saying that goes some thing like this.."don't cook bacon naked" I feel applies to this situation that we are watching unfold
i was skeptic of whole marijuana space and wanted exposure. so the peace of mind the US program put in my head was why i made a big concentrated bet in this name. I still believe in the science especially when they focused on glaucoma since all early studies during vietnam era showed the stuff worked when smoked so how could these studies ever fail??
figured the partnership with Mississippi made this an easy acquisition target for someone, guess i was wrong
.39 avg but i started buying around announcement of schneider bros financing around .48 then i got .12 after that failed to help lower and then have bought at intermittent times since then
I just want to be positive on the trade i deserve that for believing for past 24 months
Another nothing announcement
today's 8k makes it seem like they're moving along
https://www.marketwatch.com/story/short-sellers-are-increasing-bets-that-cannabis-stocks-will-fall-2019-08-01
Good article on short sellers that sheds light on the high rates you have to pay to borrow stocks in the sector
market makers (20 years experience as equity options market maker) are obligated to maintain a fair and orderly market occasionally they will get caught short its all a factor of order flow it could be anyone acting as a BD doesnt have to be some dedicated MM. If this stock were in an ETF or holder you could then technically create synthetic shorts by shorting the etf and buying the other components but that is not case hear. All the financing rounds were very transparent prior, there was a big holder of the stock called Sabby Capital and 3 other officers (other than Murphy) that received incentive based compensation, the underwriter that received compensation thru stock, and the 7 or so various investors so its easy to see "where the bodies lie". I'm guessing this is a dangerous game of attempted stock manipulation across the sector by some group of related parties and in due time they will get crushed by some irrational moment in market behavior.
Yes they need to give us preIND update.
Cant be borrowed trust me. If not I would gladly lend my million shares at the rates they offer for other mmj stocks
Its US listed otc stock theres no such thing as short. The only shorts technically is anyone acting as a market maker / specialist. There are ways around this but those positions would have to be short lived I imagine. Emerald created the credit facility at higher strike prices so they're not selling any of this; a credit to the strength of a stronger more experienced group like Emerald taking the reins. One day with volume 5MM shares or above this could spin out of control one way or the other quickly. A short player at these prices could get majorly hurt I dont think there's a clearing house left that would allow that type of risk, since anyone controlling a decent amount money on a short play of this name would have to be short multiple millions in order to create a return of any significance. I've seen pennies like this such as AXIM hit $15+ relatively quickly, I can't imagine a short that would take that poor risk reward on something like this. What the hell do I know
The sector has been creamed. These companies have been radio silent w announcements in July. S&P finally cooled down and Bitcoin seems to be back on the road to zero. All signs post to big move up in due time, but these guys need to start moving the science along. I agree this is a great level to load up at.
they'll take as much as they can. I'm not so sure they have ever had drugs further than phase 2, so they will keep funding until that point they can get a deal. They need to move the science along bottom line
this type of program seller is some type of algo used by the guys who sell penny stock securities (ie Glendale Securities or something similar). Its definitely some hard up former partner / or investor (less likely) that doesnt have the money to have his stock accepted where they bank so they have to use one of the street shops.
there are no more "insiders" since all stock prior to emerald was converted to common shares. I'm referring to the lady, lykos, and ingham who all have shares in plenitude to sell if they needed money
This is a previous insider selling, probably nothing related to company was factor for sale. This stock has very limited access to short sellers its chart price mirrors other stocks usually trading at same ranges such as axim or imlff, sector has had a rough 90 days. They keep moving forward on science and meeting timelines were good. Ocular science has shorter testing periods so better payoff time horizon as other early stage biotech plays. Cant wait for them to actually initiate their first in human trials .